Improving Pre-Clinical Safety Assessment with Microphysiological Systems
Time: 12:15 pm
day: Day 2 Track B AM
Details:
- Outline the context of use of microphysiological systems (MPS) to generate safety and efficacy data for drug development with improved clinical relevance over more traditional 2D cell culture and animal models
- Highlight examples of data generated from these systems that demonstrate the utility of MPS for safety assessment
- Current challenges to the adoption and/or development of MPS in the pharmaceutical industry
